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bers of this genus other than baumannii have been recognized
as a result of the implementation of new technologies in diag-
nostic laboratories. Acinetobacter junii is an atypical human path-
ogen that has been mainly associated with bacteraemia in
neonates and paediatric oncology patients. Some cases of men-
ingitis, peritonitis, ocular infection and septicaemia caused by
A. junii have been reported [1]. Moreover, many recently pub-
lished reports of Acinetobacter spp. harbouring blaNDM suggested
Acinetobacter as the source and cause of spread for this threat-
ening carbapenemase [2–6]. The identiﬁcation of blaNDM-1 was
recently described in A. junii clinical isolates from China [6,7].
Here we report the presence of a clinically signiﬁcant A. junii
blaNDM-1 positive in a 38-year-old woman who was admitted to
the emergency department with a fever and leg ulcers with
signs of infection. She presented a history of bipolar disorder,
hypothyroidism, obesity and chronic necrotizing vasculitis. She
had received treatment with corticosteroids and rituximabNew Microbes and New Infections © 2016 The Authors. Published by El
This is an open access artiseveral months before. Fine-needle puncture aspiration of the
ulcers was performed, and empiric treatment with piperacillin/
tazobactam at 4.5 g/6 hours was administered intravenously
plus vancomycin at 1 g/12 hours administered intravenously.
Aspiration samples from the infected ulcers were cultured
and grew Enterobacter cloacae after 24 hours of incubation. The
isolate was carbapenem susceptible, and the presence of
extended β-lactamase activity was detected by Clinical and
Laboratory Standards Institute (CLSI) guidelines. Considering
the antibiotic susceptibility report, the antimicrobial therapy
was changed to ertapenem at 1 g/24 hours, which resulted in
the patient recovering well. After 8 days, she became febrile;
therefore, the central venous catheter was removed, one blood
culture was obtained and vancomycin was added to the anti-
microbial therapy.
After 18 hours of incubation, the growth of a Gram-
negative, nonfermenting, rod-shaped bacterium, originally
identiﬁed as Acinetobacter spp., was identiﬁed from both cath-
eter tip and blood culture samples via conventional biochem-
ical tests. The Acinetobacter spp. isolate 23910 was further
identiﬁed by matrix-assisted laser desorption/ionization time-
of-ﬂight mass spectrometry (MALDI-TOF) MS (Bruker Dal-
tonics), rpoB ampliﬁcation and sequencing to arrive to the
species level. MALDI-TOF identiﬁed the strain as A. junii, with a
score of 2.34. This result was conﬁrmed with rpoB sequence
analysis, which showed 99% identity with A. junii strain CIP
107470 (accession no. DQ207483, previously named as
A. grimontii). The antibiotic susceptibility test was performed
using the Phoenix Automated Microbiology System (Becton
Dickinson, Franklin Lakes, NJ, USA) using panel NMIC/ID 92
(Gram-negative susceptibility card). The minimum inhibitory
concentration (MIC) results were interpreted using the CLSI
categories. The MIC results for the tested antibiotics were as
followed (μg/mL): ampicillin >16; ampicillin/sulbactam 8/4;
piperacillin/tazobactam 16/4; cefazolin >8, cephalotin >16;
cefoxitin >16; ceftriaxone >4; ceftazidime >16; cefepime >16;
ertapenem >1; imipenem >8; meropenem >8; amikacin 8;
gentamicin 2; colistin 1; trimethoprim/sulfamethoxazole
0.5/9.5; ciproﬂoxacin 1; levoﬂoxacin 1; fosfomycin >64.
These results revealed that Aj23910 was susceptible to the
following: ampicillin/sulbactam, piperacillin/tazobactam, amika-
cin, gentamicin, colistin, trimethoprim/sulfamethoxazole, cip-
roﬂoxacin and levoﬂoxacin. It was resistant to ampicillin,
cefazolin, ceftriaxone, cefoxitin, ceftazidime, cefepime, ertape-
nem, meropenem, imipenem and fosfomycin-G6P.
After the antimicrobial susceptibility report for this strain,
the antimicrobial therapy was changed again to ampicillin/sul-
bactam at 1.5 g/6 hours administered intravenously. The clinical
ﬁnding—the same as A. junii isolate recovered from the bloodNew Microbe and New Infect 2016; 11: 43–44
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bacteraemia associated with venous central catheter.
In order to test for the presence of metallo-β-lactamase
(MBL), we performed disk diffusion assays and a double-disk
assay using an EDTA/SMA disk (1900/750 μg per disk,
respectively) (Laboratorios Britania, Buenos Aires, Argentina)
and an imipenem disk (placed 15 mm from each other). This
assay showed synergism between carbapenem and EDTA/SMA
disks, which suggests the presence of a putative MBL present in
Aj23910. Considering the results, we decided to search for the
most widespread MBL genes by PCR ampliﬁcation. Total DNA
extraction was performed according to the manufacturer’s in-
structions (Promega, Madison, WI, USA). We carried out PCR
reactions using previously described primers to determine the
presence of blaVIM, blaIMP, blaNDM and blaSPM genes [4]. The
reactions were performed using GoTaq enzyme according to
the manufacturer’s instructions (Promega). We obtained posi-
tive results for the ampliﬁcation of blaNDM-1 in the Aj23910
strain. Nucleotide sequencing and sequence analysis of the
positive ampliﬁcation showed 100% identity with blaNDM1. We
also obtained positive results for ISAba125 and aphA6 genes,
which were previously reported in the same genetic context as
NDM [3,4,8]. PCR reactions revealed the link and proximity of
these genes to blaNDM-1. Positive PCR products (blaNDM-1 F-
ISAba125F, blaNDM-1 R-ISAba125F, blaNDM-1 R-aphA6F,
aphA6F- ISAba125F and aphA6F-ISAba125R) were sequenced.
The sequence analyses conﬁrmed the presence of aphA6-
ISAba125–blaNDM-1 association.
In addition, conjugation assays were performed to see if
blaNDM-1 was plasmid located. Brieﬂy, Aj23910 and Escherichia
coli J53-2 cells grown with agitation in Luria Bertani (LB) broth
were mixed (1:10 and 5:10 donor:recipient) and incubated for
18 hours at 30°C. Transconjugant cells were selected on LB
agar supplemented with sodium azide (150 μg/mL) and ampi-
cillin (100 μg/mL) and were incubated overnight at 37°C. The
negative results from the conjugation assay suggests that
blaNDM-1 is codiﬁed in a nonconjugative element. Further
studies are required to determine whether the gene possessed
a chromosome location or a nonconjugative element location.
The NDM-1 carbapenemase has been dramatically spread
among Gram-negative bacilli, thus imposing a new challenge on
the health system to ﬁght bacterial infections.
These data expand the number of Acinetobacter species har-
bouring blaNDM-1. The wide existence of Acinetobacter harbouringNew Microbes and New Infections © 2016 The Authors. Published by Elsevier Ltd on behalf of
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non–previously recognized pathogens as reservoirs of dangerous
resistance determinants. These resistance determinants can be
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